Loading resource…

Health & Science University, Portland, OR, USA
Acromegaly is primarily caused by growth hormone-secreting pituitary adenomas, which are typically benign but can lead to significant morbidity. The review discusses the epidemiology, pathogenesis, complications, and treatment options available for acromegaly. Key therapeutic goals include normalizing IGF-1 and growth hormone levels, tumor shrinkage, and managing associated comorbidities. The document highlights the need for individualized treatment approaches to improve patient quality of life.
No account needed